Rare diseases
Investigational molecules
Locations
A study testing how well cagrilintide and semaglutide help people with overweight or obesity lose weight
FranceA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
FranceStudy of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment
FranceStudy of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years
FranceStudy of SAR442970 to treat moderate to severe ulcerative colitis in adults
FranceStudy of tarlatamab alone or with FOLFIRI chemotherapy for patients with advanced digestive system or unknown origin neuroendocrine carcinomas
FranceStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
FranceStudy of tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)
FranceLong-term safety study of NNC6019-0001 for patients with transthyretin amyloid cardiomyopathy (ATTR-CM)
FranceStudy of fampridine treatment for patients with spinocerebellar ataxia SCA27B caused by FGF14 gene mutation
FranceStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
FranceLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
